Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study-Reference-Cited by-同舟云学术

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

Published:2022-09 Issue: Volume:51 Page:101542
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Ascaso-del-Rio Ana^ORCID,García-Pérez Javier,Pérez-Olmeda Mayte,Arana-Arri Eunate,Vergara Itziar,Pérez-Ingidua Carla,Bermejo Mercedes,Castillo de la Osa María,Imaz-Ayo Natale,Riaño Fernández Ioana,Astasio González Oliver,Díez-Fuertes Francisco,Meijide Susana,Arrizabalaga Julio,Hernández Gutiérrez Lourdes,de la Torre-Tarazona Humberto Erick,Mariano Lázaro Alberto,Vargas-Castrillón Emilio,Alcamí José^ORCID,Portolés Antonio^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. European Centre for Disease Prevention and Control (ECDC), an agency of the European Union. SARS-CoV-2 variants of concern as of 27 January 2022. https://www.ecdc.europa.eu/en/covid-19/variants-concern. Accessed 31 January 2022.

2. Emerging SARS-CoV-2 variants: a review of its mutations, its implications and vaccine efficacy;Ramesh;Vaccines (Basel),2021

3. European Centre for Disease Prevention and Control (ECDC). COVID-19 Vaccine Tracker.https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab. Accessed 12 December 2021.

4. European Medicines Agency (EMA). Comirnaty and Spikevax: EMA recommendations on extra doses and boosters. 2021. https://www.ema.europa.eu/en/news/comirnaty-spikevax-ema-recommendations-extra-doses-boosters. Accessed 15 November 2021.

5. COVID-19 vaccines: the status and perspectives in delivery points of view;Chung;Adv Drug Deliv Rev,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity, clinical efficacy and safety of additional second COVID‐19 booster vaccines against Omicron and its subvariants: A systematic review;Reviews in Medical Virology;2024-01

2. Prostate-specific antigen level association with COVID-19 infection and vaccination;Clinical Genitourinary Cancer;2023-12

3. Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: a test-negative, case-control study;The Lancet Regional Health - Southeast Asia;2023-03

4. Treatment with integrase inhibitors alters SARS‐CoV‐2 neutralization levels measured with HIV‐based pseudotypes in people living with HIV;Journal of Medical Virology;2023-02

5. Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history;Cell Host & Microbe;2022-12